What Happened
On March 30, 2026, the Departments of Labor, Health and Human Services, and Treasury filed a joint status report in ERIC v. HHS (D.D.C.) disclosing that they will no longer defend the September 2024 Mental Health Parity and Addiction Equity Act (MHPAEA) final rule. Instead, the agencies committed to proposing “significant revisions” by December 31, 2026, with a court-supervised progress update due September 30.
The 2024 rule had introduced new requirements for nonquantitative treatment limitation (NQTL) comparative analyses, a “meaningful benefits” standard for mental health and substance use disorder (MH/SUD) coverage, and plan fiduciary certification of a “prudent process” for monitoring service providers. Those provisions are now paused. But the underlying MHPAEA statute, the 2013 final rule, and the Consolidated Appropriations Act (CAA) 2021 comparative analysis mandate remain fully enforceable.
Who It Affects
Self-funded employer health plans bear the sharpest exposure. Unlike fully insured arrangements where the carrier owns the compliance burden, self-funded sponsors are ultimately responsible for MHPAEA compliance regardless of what their TPA or PBM handles operationally. That responsibility extends to the NQTL comparative analysis the CAA requires.
The agencies’ fourth MHPAEA report to Congress, published in March 2026, underscores how far the compliance gap extends. Of 85 comparative analyses the agencies requested during the two-year reporting period, 76 received insufficiency letters on first submission. Fifteen plans received final noncompliance determinations. As we covered when the fourth report dropped, the compliance gap sits with the plan, not the vendor.
The Reserve Problem
The enforcement pause does not eliminate behavioral health cost risk. It redistributes that risk across time, and self-funded plans pricing plan-year 2027 budgets this summer face an expected claim ratio problem for MH/SUD benefits that has no stable regulatory anchor.
If the replacement rule tightens access standards (expanding MH/SUD network adequacy requirements, shortening prior authorization windows), plans will face a step-function increase in behavioral health utilization. Claims managed down during the pause will catch up in a compressed window, creating adverse development in the behavioral health component of health plan IBNR.
If the replacement rule loosens standards relative to the 2024 version, plans that pre-invested in parity compliance will have loaded utilization assumptions that overshoot actual claims. Either direction creates a miss.
Stop-loss carriers pricing January 2027 renewals face the same calibration problem. They cannot anchor behavioral health underwriting to a regulatory framework that may not exist in its current form when the policy year begins. Expect wider behavioral health rate bands and tighter sublimits in renewal proposals. Plans already navigating stop-loss repricing from GLP-1 and gene therapy utilization now have a second source of underwriting uncertainty layered on top.
What This Means for Your Next Review
If your plan’s MH/SUD IBNR estimate uses a single expected claim ratio, ask your actuary to run a sensitivity band around that assumption. The range should reflect both a pre-2024 baseline (2013 rule requirements only) and a post-reform scenario where NQTL restrictions narrow. Document the range and the rationale now. When the replacement rule lands, you will have a framework for adjusting rather than starting from scratch.
State parity laws add another layer. At least 10 states enforce MH/SUD parity standards that exceed the 2013 federal floor. Plans with multi-state covered populations should confirm whether state requirements, not just the federal pause, govern their NQTLs. The ERISA fiduciary exposure building around plan sponsor oversight makes documentation of this analysis a protective step, not just a compliance exercise.
The September 30 court status update in ERIC v. HHS will signal whether the agencies are on track. If the December deadline slips, the litigation resumes and the 2024 rule could be reinstated. Build your 2027 budget to absorb either outcome.
Sources
- Mercer analysis of March 30, 2026 joint status report in ERIC v. HHS
- DOL enforcement statement on MHPAEA final rule (May 2025)
- ERISA Litigation Blog: fourth MHPAEA Report to Congress takeaways
- Lockton: comparative analysis requirement still stands
- Crowell & Moring: tri-agencies release fourth mental health parity report